Tuesday, January 13, 2015 11:16:00 AM
1-13-15: HeartWare Announces Prelim. Q4’14 Revenues of ~73mm; up 38% from Q4 in 2013
• 2014 Prelim. Revenues ~$278mm; 34% incr. from 2013
http://www.prnewswire.com/news-releases/heartware-international-announces-preliminary-fourth-quarter-2014-revenues-300019689.html
FRAMINGHAM, Jan. 13, 2015: HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it expects revenues for Q4/’14 will be ~$73mm, bringing expected 2014 revenues to ~$278mm.
"Our full-year revenue growth of 34% for 2014 above 2013 reflects the strong market penetration we have experienced to date for the HeartWare Ventricular Assist System in both the U.S. and intl. markets," said Doug Godshall, President and CEO. "Q4/2014 unit sales increased by ~9% sequentially compared to Q3/2014, a key driver of our strong revenue performance…”
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM